Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mercedes Robledo

Showing results (91-100 of 215) with videos related to

Pageof 22
Sort By:
Discover Oncology|February 24, 2022
Metastatic pheochromocytoma and paraganglioma: signs and symptoms related to catecholamine secretionMinghao Li, Christina Pamporaki, Stephanie M J Fliedner, et al.
European Journal of Endocrinology|October 16, 2019
Metabolic impact of pheochromocytoma/paraganglioma: targeted metabolomics in patients before and after tumor removalZoran Erlic, Max Kurlbaum, Timo Deutschbein, et al.
Endocrine-Related Cancer|July 20, 2007
Overexpression of the S-phase kinase-associated protein 2 in thyroid cancerGennaro Chiappetta, Carmela De Marco, Alfina Quintiero, et al.
Journal of Medical Genetics|April 12, 2012
Shorter telomere length is associated with increased ovarian cancer risk in both familial and sporadic casesBeatriz Martinez-Delgado, Kira Yanowsky, Lucia Inglada-Perez, et al.
Orphanet Journal of Rare Diseases|March 1, 2022
Considerations on diagnosis and surveillance measures of PTEN hamartoma tumor syndrome: clinical and genetic study in a series of Spanish patientsLaura Pena-Couso, María Ercibengoa, Fátima Mercadillo, et al.
The Journal of Clinical Endocrinology and Metabolism|December 30, 2004
Succinate dehydrogenase D variants do not constitute a risk factor for developing C cell hyperplasia or sporadic medullary thyroid carcinomaAlberto Cascon, Arancha Cebrian, Marina Pollan, et al.
Journal of Clinical Medicine|July 8, 2020
A Novel Approach for the Identification of Pharmacogenetic Variants in <i>MT-RNR1</i> through Next-Generation Sequencing Off-Target DataJavier Lanillos, María Santos, Marta Carcajona, et al.
The Journal of Clinical Endocrinology and Metabolism|April 2, 2014
H-RAS mutations are restricted to sporadic pheochromocytomas lacking specific clinical or pathological features: data from a multi-institutional seriesLindsey Oudijk, Ronald R de Krijger, Ida Rapa, et al.
Plos One|October 3, 2013
An epistatic interaction between the PAX8 and STK17B genes in papillary thyroid cancer susceptibilityIñigo Landa, Cesar Boullosa, Lucía Inglada-Pérez, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 14, 2021
Prevalence of pathogenic germline variants in patients with metastatic renal cell carcinomaMaría Santos, Javier Lanillos, Juan María Roldan-Romero, et al.
Pageof 22

Showing results (91-100 of 215) with videos related to

Sort By:
Pageof 22
Discover Oncology|February 24, 2022
Metastatic pheochromocytoma and paraganglioma: signs and symptoms related to catecholamine secretionMinghao Li, Christina Pamporaki, Stephanie M J Fliedner, et al.
European Journal of Endocrinology|October 16, 2019
Metabolic impact of pheochromocytoma/paraganglioma: targeted metabolomics in patients before and after tumor removalZoran Erlic, Max Kurlbaum, Timo Deutschbein, et al.
Endocrine-Related Cancer|July 20, 2007
Overexpression of the S-phase kinase-associated protein 2 in thyroid cancerGennaro Chiappetta, Carmela De Marco, Alfina Quintiero, et al.
Journal of Medical Genetics|April 12, 2012
Shorter telomere length is associated with increased ovarian cancer risk in both familial and sporadic casesBeatriz Martinez-Delgado, Kira Yanowsky, Lucia Inglada-Perez, et al.
Orphanet Journal of Rare Diseases|March 1, 2022
Considerations on diagnosis and surveillance measures of PTEN hamartoma tumor syndrome: clinical and genetic study in a series of Spanish patientsLaura Pena-Couso, María Ercibengoa, Fátima Mercadillo, et al.
The Journal of Clinical Endocrinology and Metabolism|December 30, 2004
Succinate dehydrogenase D variants do not constitute a risk factor for developing C cell hyperplasia or sporadic medullary thyroid carcinomaAlberto Cascon, Arancha Cebrian, Marina Pollan, et al.
Journal of Clinical Medicine|July 8, 2020
A Novel Approach for the Identification of Pharmacogenetic Variants in <i>MT-RNR1</i> through Next-Generation Sequencing Off-Target DataJavier Lanillos, María Santos, Marta Carcajona, et al.
The Journal of Clinical Endocrinology and Metabolism|April 2, 2014
H-RAS mutations are restricted to sporadic pheochromocytomas lacking specific clinical or pathological features: data from a multi-institutional seriesLindsey Oudijk, Ronald R de Krijger, Ida Rapa, et al.
Plos One|October 3, 2013
An epistatic interaction between the PAX8 and STK17B genes in papillary thyroid cancer susceptibilityIñigo Landa, Cesar Boullosa, Lucía Inglada-Pérez, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 14, 2021
Prevalence of pathogenic germline variants in patients with metastatic renal cell carcinomaMaría Santos, Javier Lanillos, Juan María Roldan-Romero, et al.
Pageof 22